Search research articles
Contact Us
Filters
Showing results (181-190 of 1,428) with videos related to
Page
of 143
Sort By:
Circulation Research
|
August 21, 2010
Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins
Michael J Ackerman, Peter J Mohler
Annual Review of Medicine
|
October 22, 2008
Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children
David J Tester, Michael J Ackerman
Nature Reviews. Cardiology
|
February 1, 2012
Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy
John R Giudicessi, Michael J Ackerman
Circulation
|
December 8, 2010
Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy
Andrew P Landstrom, Michael J Ackerman
Clinical Pharmacology and Therapeutics
|
September 22, 2011
The Achilles' heel of cardiovascular genetic testing: distinguishing pathogenic mutations from background genetic noise
A P Landstrom, M J Ackerman
The Journal of Biological Chemistry
|
October 5, 1990
Ribozymes correctly cleave a model substrate and endogenous RNA in vivo
S K Saxena, E J Ackerman
Research in Developmental Disabilities
|
January 1, 1993
Who is treated using restrictive behavioral procedures? A population perspective
J W Jacobson, L J Ackerman
Journal of Neurosurgery. Spine
|
May 9, 2014
Response
Stacey J Ackerman, David W Polly
Circulation. Cardiovascular Genetics
|
August 22, 2013
Arrhythmia risk in long QT syndrome: beyond the disease-causative mutation
John R Giudicessi, Michael J Ackerman
Circulation. Genomic and Precision Medicine
|
March 14, 2020
Established Loss-of-Function Variants in <i>ANK2</i>-Encoded Ankyrin-B Rarely Cause a Concerning Cardiac Phenotype in Humans
John R Giudicessi, Michael J Ackerman
Page
of 143
Search research articles
Search
Showing results (181-190 of 1,428) with videos related to
Sort By:
Page
of 143
Circulation Research
|
August 21, 2010
Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins
Michael J Ackerman, Peter J Mohler
Annual Review of Medicine
|
October 22, 2008
Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children
David J Tester, Michael J Ackerman
Nature Reviews. Cardiology
|
February 1, 2012
Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy
John R Giudicessi, Michael J Ackerman
Circulation
|
December 8, 2010
Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy
Andrew P Landstrom, Michael J Ackerman
Clinical Pharmacology and Therapeutics
|
September 22, 2011
The Achilles' heel of cardiovascular genetic testing: distinguishing pathogenic mutations from background genetic noise
A P Landstrom, M J Ackerman
The Journal of Biological Chemistry
|
October 5, 1990
Ribozymes correctly cleave a model substrate and endogenous RNA in vivo
S K Saxena, E J Ackerman
Research in Developmental Disabilities
|
January 1, 1993
Who is treated using restrictive behavioral procedures? A population perspective
J W Jacobson, L J Ackerman
Journal of Neurosurgery. Spine
|
May 9, 2014
Response
Stacey J Ackerman, David W Polly
Circulation. Cardiovascular Genetics
|
August 22, 2013
Arrhythmia risk in long QT syndrome: beyond the disease-causative mutation
John R Giudicessi, Michael J Ackerman
Circulation. Genomic and Precision Medicine
|
March 14, 2020
Established Loss-of-Function Variants in <i>ANK2</i>-Encoded Ankyrin-B Rarely Cause a Concerning Cardiac Phenotype in Humans
John R Giudicessi, Michael J Ackerman
Page
of 143